Nathen Fuentes's most recent trade in Renovaro Biosciences Inc was a trade of 250,000 Option to purchase shares of common stock done . Disclosure was reported to the exchange on Jan. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Renovaro Biosciences Inc | Nathen Fuentes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 250,000 | 250,000 | - | - | Option to purchase shares of common stock |